共 152 条
[1]
Vogel CL(2002)Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer J Clin Oncol 20 719-726
[2]
Cobleigh MA(2003)Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma Cancer 97 2972-2977
[3]
Tripathy D(2016)Breast cancer brain metastases: biology and new clinical perspectives Breast Cancer Res 18 8-3747
[4]
Gutheil JC(2016)Leptomeningeal metastasis in breast cancer—a systematic review Oncotarget 7 3740-92
[5]
Harris LN(2013)A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer J Neurooncol 113 83-e155
[6]
Fehrenbacher L(2015)Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients BMC Cancer 15 1021-1980
[7]
Slamon DJ(2016)Intrathecal trastuzumab halts progression of CNS metastases in breast cancer J Clin Oncol 34 e151-847
[8]
Murphy M(2015)Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient J Immunother Cancer 3 41-1377
[9]
Novotny WF(2008)High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer Ann Oncol 19 1978-22
[10]
Burchmore M(2016)Intrathecal trastuzumab treatment in patients with breast cancer and leptomeningeal carcinomatosis Cancer Res Treat 48 843-126